glutathione reductase deficiency anaemia Glucose-6-Phosphate Dehydrogenase (G6PD) Role of riboflavin deficiency in

Sulforaphane, an Nrf2 activator, induces NQO1 activity and improves the function of the neurovascular unit following TBI by reducing the loss of endothelial cells and tight junction proteins and preserving bloodbrain barrier integrity [210]

Ko, E., Yoon, E

Glossary AAs African Americans ACCORD-MIND Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes ACE angiotensin-converting enzyme AGE advanced glycation end product Agt angiotensinogen Ang I angiotensin I Ang II angiotensin II APOL1 apolipoprotein L1 APP/PS1 amyloid precursor protein/presenilin 1 ARB angiotensin receptor blocker ARIC Atherosclerosis Risk in Communities AT1R angiotensin II type 1 receptor BBB blood-brain barrier BRINK Brain in Kidney Disease Cho choline CKD chronic kidney disease CRP C-reactive protein CSF cerebrospinal fluid cSVD cerebral small vessel disease CX3CR1 C-X3-C motif chemokine receptor 1 DC diabetic cognopathy DCCT Diabetes Control and Complications Trial DKD diabetic kidney disease DM diabetes mellitus DPP-4 dipeptidyl peptidase 4 eGFR estimated glomerular filtration rate ESRD end-stage renal disease FGF-23 fibroblast growth factor 23 FIDELIO-DKD Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease FIGARO-DKD Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease GLP-1 glucagon-like peptide 1 GM gray matter HbA1c glycosylated hemoglobin IL-1 interleukin-1 IL-6 interleukin-6 INVADE Intervention Project on Cerebrovascular Diseases and Dementia in the community of Ebersberg LADIS Leukoaraiosis and Disability Study Lp-PLA2 lipoprotein-associated phospholipase A2 MGCs microglial cells MMSE Mini-Mental State Examination MoCA Montreal Cognitive Assessment MRA mineralocorticoid receptor antagonist MRI magnetic resonance imaging mTOR mammalian target of rapamycin NAA N-acetyl aspartate NAME Nutrition, Aging, and Memory in Elders NHANES III Third National Health and Nutrition Examination Survey Nrf2 nuclear factor erythroid 2-related factor 2 RAAS renin-angiotensin-aldosterone system RAGE receptor for AGE RAS renin-angiotensin system RBP4 retinol-binding protein 4 REGARDS Reasons for Geographic and Racial Differences in Stroke ROS reactive oxygen species SBIs silent brain infarcts SGLT2i sodium-glucose cotransporter-2 inhibitor STS sodium thiosulfate TABASCO Tel Aviv Brain Acute Stroke Cohort T1DM type 1 diabetes mellitus T2DM type 2 diabetes mellitus TGF- transforming growth factor- TNF- tumor necrosis factor- UACR urine albumin-to-creatinine ratio WMH white matter hyperintensities WMLs white matter lesions

And what happens after (included follow-up, a 24/7 line, a structured review, versus none of that)

It is also utilized for the treatment of megaloblastic insignificance due to folic damaging need and when oral treatment isnt feasible